NBT Bank N A NY Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NBT Bank N A NY lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 23.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,062 shares of the medical equipment provider's stock after buying an additional 573 shares during the quarter. NBT Bank N A NY's holdings in Intuitive Surgical were worth $1,517,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. Atala Financial Inc bought a new stake in Intuitive Surgical in the fourth quarter valued at $25,000. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Global Financial Private Client LLC boosted its stake in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the sale, the executive vice president now directly owns 2,245 shares in the company, valued at approximately $1,152,089.10. The trade was a 43.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 215 shares of Intuitive Surgical stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the completion of the sale, the senior vice president now directly owns 1,768 shares of the company's stock, valued at $970,738.08. The trade was a 10.84% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

ISRG stock traded down $2.62 on Thursday, reaching $509.49. 1,173,748 shares of the company traded hands, compared to its average volume of 1,675,866. The firm has a fifty day simple moving average of $527.31 and a 200-day simple moving average of $537.92. The company has a market cap of $182.61 billion, a P/E ratio of 74.71, a price-to-earnings-growth ratio of 5.40 and a beta of 1.67. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter last year, the firm earned $1.50 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Piper Sandler cut their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price target for the stock from $515.00 to $440.00 in a report on Monday, June 9th. Citigroup reaffirmed a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Truist Financial cut their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $588.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.